早期胃癌保胃治疗中腹腔镜前哨淋巴结导航手术的随机临床试验
该随机临床试验将580例术前诊断为IA期胃腺癌(≤3 cm)患者分配至腹腔镜标准胃切除术(LSG)或腹腔镜前哨淋巴结导航手术(LSNNS),主要终点为3年无病生存率(3y-DFS)。改良意向治疗分析纳入527例(LSG组269例,LSNNS组258例),LSNNS组3y-DFS为91.8%,LSG组为95.5%,差异3.7%(95% CI,-0.6至8.1),未达到5%非劣效界值;但3年疾病特异性生存率和3年总生存率两组无差异,且LSNNS组长期生活质量和营养更好。
要点
- LSNNS组3y-DFS为91.8%,LSG组为95.5%,差异3.7%(95% CI,-0.6至8.1),未达到5%非劣效界值。
- LSNNS组3年疾病特异性生存率为99.1%,LSG组为99.5%(P=0.59);3年总生存率分别为97.6%和99.2%(P=0.17)。
- LSNNS组术后并发症发生率为15.5%,LSG组为19.0%(P=0.294);LSNNS组身体功能、症状和营养均优于LSG组。
核心结论
- LSNNS在3y-DFS方面未显示相对于LSG的非劣效性(界值5%)。
- 复发/异时性胃癌经挽救手术后,两组3y-DSS和3y-OS无差异,且LSNNS具有更好的长期生活质量和营养。
研究设计与样本
- 随机临床试验,纳入580例术前诊断为IA期胃腺癌(≤3 cm)患者,分配至LSG或LSNNS,观察者未设盲。
- 主要终点为3y-DFS;次要终点包括术后并发症、生活质量、3y-DSS和3y-OS。
- 改良意向治疗分析纳入527例(LSG组269例,LSNNS组258例)。
主要发现
- LSNNS组210例(81%)实施了保胃手术。
- LSG组和LSNNS组的3y-DFS分别为95.5%和91.8%,差异3.7%(95% CI,-0.6至8.1)。
- LSNNS组3例复发和5例异时性胃癌患者接受了标准手术;两组各2例远处转移患者接受姑息化疗。
- LSG组和LSNNS组的3y-DSS分别为99.5%和99.1%(P=0.59),3y-OS分别为99.2%和97.6%(P=0.17)。
- 术后并发症发生率LSG组为19.0%,LSNNS组为15.5%(P=0.294);LSNNS组身体功能更佳(P=0.015)、症状更少(P<0.001)且营养改善优于LSG组。
局限性
- 观察者未对患者分组设盲。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To compare postoperative complications, long-term survival, and quality of life (QOL) after laparoscopic sentinel node navigation surgery (LSNNS) and laparoscopic standard gastrectomy (LSG). METHODS: Five hundred eighty patients with preoperatively diagnosed stage IA gastric adenocarcinoma (≤ 3 cm) were assigned to undergo either LSG or LSNNS. Observers were not blinded to patient grouping. The primary outcome was 3-year disease-free survival (3y-DFS). Secondary outcomes included postoperative complications, QOL, 3-year disease-specific survival (3y-DSS), and 3-year overall survival (3y-OS). RESULTS: In total, 527 patients were included in the modified intention-to-treat analysis population for the primary outcome (LSG, 269; LSNNS, 258). Stomach-preserving surgery was performed in 210 patients (81%) in the LSNNS group. During the median follow-up duration, the 3y-DFS rates in the LSG and LSNNS groups were 95.5% and 91.8%, respectively (difference: 3.7%; 95% CI, -0.6 to 8.1). Three patients with recurrence and five with metachronous gastric cancer in the LSNNS group underwent standard surgery. Two patients with distant metastasis in both groups were treated with palliative chemotherapy. The 3y-DSS and 3y-OS rates in the LSG and LSNNS groups were 99.5% and 99.1% (P = .59) and 99.2% and 97.6% (P = .17), respectively. Postoperative complications occurred in 19.0% of the LSG group and 15.5% of the LSNNS group (P = .294). The LSNNS group showed better physical function (P = .015), less symptoms (P < .001), and improved nutrition than the LSG group. CONCLUSION: LSNNS did not show noninferiority to LSG for 3y-DFS, with a 5% margin. However, the 3y-DSS and 3y-OS were not different after rescue surgery in cases of recurrence/metachronous gastric cancer, and LSNNS had better long-term QOL and nutrition than LSG.
引用
- Kim YW, Min JS, Yoon HM, et al. Laparoscopic Sentinel Node Navigation Surgery for Stomach Preservation in Patients With Early Gastric Cancer: A Randomized Clinical Trial. J Clin Oncol. 2022. PMID: 35324317. doi:10.1200/JCO.21.02242
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。